• 1
    Burnstock G, Ralevic V. New insights into the local regulation of blood flow by perivascular nerves and endothelium. Br J Plast Surg 1994; 47: 52743.
  • 2
    Belai A, Milner P, Aberdeen J, Burnstock G. Selective damage to sensorimotor perivascular nerves in the mesenteric vessels of diabetic rats. Diabetes 1996; 45: 13943.
  • 3
    Kondo M, Fujiwara T, Miyazaki T, Terade M, Tabei R. Noradrenergic hyperinnervation may inhibit necrosis of coronary arterial smooth muscle cells in stroke-prone spontaneously hypertensive rats. Virchows Arch 1997; 430: 715.
  • 4
    Marin J, Redondo J. Vascular sodium pump: endothelial modulation and alterations in some pathological processes and ageing. Pharmacol Ther 1999; 84: 24971.
  • 5
    Ralevic V, Burnstock G. Involvement of purinergic signalling in cardiovascular diseases. Drug News Perspect 2003; 16: 13340.
  • 6
    Jansen I, Uddman R, Ekman R, Olesen J, Ottosson A, Edvinsson L. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides 1992; 13: 52736.
  • 7
    Pounder RE. The pathogenesis of Crohn’s disease. J Gastroenterol 1994; 29: 115.
  • 8
    Foitzik T, Kruschewski M, Kroesen A, Buhr HJ. Does microcirculation play a role in the pathogenesis of inflammatory bowel diseases? Answers from intravital microscopic studies in animal models. Int J Colorectal Dis 1999; 14: 2934.
  • 9
    Mori M, Stokes KY, Vowinkel T et al. Colonic blood flow responses in experimental colitis: time course and underlying mechanisms. Am J Physiol Gastrointest Liver Physiol 2005; 289: G10249.
  • 10
    Burnstock G. Cotransmission. Curr Opin Pharmacol 2004; 4: 4752.
  • 11
    Bobalova J, Mutafova-Yambolieva VN. Presynaptic α2-adrenoceptor-mediated modulation of adenosine 5′ triphosphate and noradrenaline corelease: differences in canine mesenteric artery and vein. J Auton Pharmacol 2001; 21: 4755.
  • 12
    Galligan JJ, Hess MC, Miller SB, Fink GD. Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats. J Pharmacol Exp Ther 2001; 296: 47885.
  • 13
    Buwalda J, Colnot DR, Bleys RL, Groen GJ, Thrasivoulou C, Cowen T. Imaging and analysis of perivascular nerves in human mesenteric and coronary arteries: a comparison between epi-fluorescence and confocal microscopy. J Neurosci Methods 1997; 73: 12934.
  • 14
    Griffith SG, Burnstock G. Immunohistochemical demonstration of serotonin in nerves supplying human cerebral and mesenteric blood vessels: some speculations about their involvement in vascular disorders. Lancet 1983; 321: 5612.
  • 15
    Hutri-Kähönen N, Kähönen M, Jolma P et al. Control of mesenteric arterial tone in vitro in humans and rats. Naunyn Schmiedeberg’s Arch Pharmacol 1999; 359: 32230.
  • 16
    Phillips RJ, Hargrave SL, Rhodes BS, Zopf DA, Powley TL. Quantification of neurons in the myenteric plexus: an evaluation of putative pan-neuronal markers. J Neurosci Methods 2004; 133: 99107.
  • 17
    Meehan AG, Kreulen DL. A capsaicin-sensitive inhibitory reflex from the colon to mesenteric arteries in the guinea-pig. J Physiol (London) 1992; 448: 1539.
  • 18
    Thornton M, Solomon MJ. Crohn’s disease: in defense of a microvascular aetiology. Int J Colorectal Dis 2002; 17: 28797.
  • 19
    Hainsworth R. Vascular capacitance: its control and importance. Rev Physiol Biochem Pharmacol 1986; 105: 10173.
  • 20
    Burnstock G. Structural and chemical organisation of the autonomic neuroeffector system. In: BolisCL, LicinioJ, GovoniS, eds. Handbook of the Autonomic Nervous System in Health and Disease. New York: Marcel Dekker, Inc, 2002: 154.
  • 21
    Nichols K, Staines W, Krantis A. Neural sites of the human colon colocalize nitric oxide synthase- related NADPH diaphorase activity and neuropeptide Y. Gastroenterology 1994; 107: 96875.
  • 22
    Modin A. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide. Acta Physiol Scand Suppl 1994; 622: 174.
  • 23
    Hansen MB, Dresner LS, Wait RB. Profile of neurohumoral agents on mesenteric and intestinal blood flow in health and disease. Physiol Res 1998; 47: 30727.
  • 24
    Shen Z, Klover-Stahl B, Larsson LT, Malmfors G, Ekblad E, Sundler F. Peptide-containing neurons remain unaffected after intestinal autotransplantation: an experimental study in the piglet. Eur J Pediatr Surg 1993; 3: 2717.
  • 25
    Pascual DW, Kiyono H, McGhee JR. The enteric nervous and immune systems: interactions for mucosal immunity and inflammation. Immunomethods 1994; 5: 5672.
  • 26
    Kubota Y, Petras RE, Ottaway CA, Tubbs RR, Farmer RG, Fiocchi C. Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease. Gastroenterology 1992; 102: 124251.
  • 27
    Mazumdar S, Das KM. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease. Am J Gastroenterol 1992; 87: 17681.
  • 28
    O’Morain C, Bishop AE, McGregor GP et al. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. Gut 1984; 25: 5761.
  • 29
    Aberdeen J, Milner P, Lincoln J, Burnstock G. Guanethidine sympathectomy of mature rats leads to increases in calcitonin gene-related peptide and vasoactive intestinal polypeptide-containing nerves. Neuroscience 1992; 47: 45361.
  • 30
    Eysselein VE, Sternini C, Cominelli F, Nast CC. Putative mediators in inflammatory bowel disease: substance P and calcitonin gene-related peptide. In: SnapeWJ, CollinsSM, eds. Effects of Immune Cells and Inflammation on Smooth Muscle and Enteric Nerves. Boca Raton: CRC Press, 1991: 28193.
  • 31
    Brain SD. Sensory neuropeptides: their role in inflammation and wound healing. Immunopharmacology 1997; 37: 13352.
  • 32
    Dhatt N, Buchan AM. Colocalization of neuropeptides with calbindin D28k and NADPH diaphorase in the enteric nerve plexuses of normal human ileum. Gastroenterology 1994; 107: 68090.
  • 33
    Verbeuren TJ, Jordaens FH, Herman AG. Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog. J Pharmacol Exp Ther 1983; 226: 57988.
  • 34
    Furness JB, Costa M. Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: their projections in the guinea-pig small intestine. Neuroscience 1982; 7: 3419.
  • 35
    El-Salhy M, Danielsson A, Stenling R, Grimelius L. Colonic endocrine cells in inflammatory bowel disease. J Intern Med 1997; 242: 4139.
  • 36
    Costedio MM, Hyman N, Mawe GM. Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum 2007; 50: 37688.
  • 37
    Belai A, Boulos P, Robson T, Burnstock G. Neurochemical coding in the small intestine of patients with Crohn’s disease. Gut 1997; 40: 76774.
  • 38
    Kyosola K, Penttila O, Salaspuro M. Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand J Gastroenterol 1977; 12: 3637.
  • 39
    Grum F, Härle P, Bataille F, Schölmerich J, Schubert TEO, Straub RH. The nerve repellent factor semaphorin 3 C and the distribution of sympathetic and sensory nerves in the colon in Crohn’s disease. Exp Dermatol 2007; 16: 374.
  • 40
    Straub RH, Stebner K, Härle P, Kees F, Falk W, Schölmerich J. Key role of the sympathetic microenvironment for the interplay of tumour necrosis factor and interleukin 6 in normal but not in inflamed mouse colon mucosa. Gut 2005; 54: 1098106.
  • 41
    Miller LE, Weidler C, Falk W et al. Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2004; 50: 115663.
  • 42
    Dvorak AM, Osage JE, Monahan RA, Dickersin GR. Crohn’s disease: transmission electron microscopic studies. III. Target tissues. Proliferation of and injury to smooth muscle and the autonomic nervous system. Hum Pathol 1980; 11: 62034.
  • 43
    Di Sebastiano P, Fink T, Weihe E, Friess H, Beger HG, Buchler M. Changes of protein gene product 9.5 (PGP9.5) immunoreactive nerves in inflamed appendix. Dig Dis Sci 1995; 40: 36672.
  • 44
    Sanovic S, Lamb DP, Blennerhassett MG. Damage to the enteric nervous system in experimental colitis. Am J Pathol 1999; 155: 10517.
  • 45
    Lomax AE, O’Reilly M, Neshat S, Vanner SJ. Sympathetic vasoconstrictor regulation of mouse colonic submucosal arterioles is altered in experimental colitis. J Physiol 2007; 583: 71930.
  • 46
    Pernow J, Svenberg T, Lundberg JM. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro. Eur J Pharmacol 1987; 136: 20718.
  • 47
    Lebuffe G, Haddad E, Desreumaux P, Gambiez L, Colombel JF, Vallet B. Impaired contractile response of mesenteric arteries in Crohn’s disease. Aliment Pharmacol Ther 2000; 14: 127985.
  • 48
    Lindgren S, Lilja B, Rosen I, Sundkvist G. Disturbed autonomic nerve function in patients with Crohn’s disease. Scand J Gastroenterol 1991; 26: 3616.
  • 49
    Ludwig D, Wiener S, Brüning A, Schwarting K, Jantschek G, Stange EF. Mesenteric blood flow is related to disease activity and risk of relapse in Crohn’s disease: a prospective follow-up study. Am J Gastroenterol 1999; 94: 294250.
    Direct Link:
  • 50
    Burnstock G. Pathophysiology and therapeutic potential of purinergic signalling. Pharmacol Rev 2006; 58: 5886.